An Open-label Phase I Study to Evaluate the Drug-drug Interaction of HSK16149 Capsule With Probenecid Tablets or Cimetidine Tablets in Healthy Subjects
Latest Information Update: 14 Dec 2023
At a glance
- Drugs Cimetidine (Primary) ; Crisugabalin (Primary) ; Probenecid (Primary)
- Indications Diabetic nephropathies; Neuralgia; Neuropathic pain; Postherpetic neuralgia
- Focus Pharmacokinetics
- Sponsors Haisco Pharmaceutical Group
- 14 Dec 2023 Status changed from recruiting to completed.
- 14 Jun 2023 Planned primary completion date changed from 31 May 2023 to 22 Jun 2023.
- 02 Jun 2023 New trial record